ALK2/3 recruitment to the immunological synapse is required for T cell activation and death.

IF 10.6 1区 医学 Q1 IMMUNOLOGY
Journal of Experimental Medicine Pub Date : 2025-10-06 Epub Date: 2025-07-30 DOI:10.1084/jem.20250121
Jun-Ge Shi, Zhen-Wu Ma, Zi-Lun Ruan, Ye Xu, Wen-Hao Hang, Rui Liu, Yong Xiong, Hong-Bing Shu, Shu Li
{"title":"ALK2/3 recruitment to the immunological synapse is required for T cell activation and death.","authors":"Jun-Ge Shi, Zhen-Wu Ma, Zi-Lun Ruan, Ye Xu, Wen-Hao Hang, Rui Liu, Yong Xiong, Hong-Bing Shu, Shu Li","doi":"10.1084/jem.20250121","DOIUrl":null,"url":null,"abstract":"<p><p>Antigen recognition by TCR triggers T cell activation and activation-induced cell death (AICD). We identified that the BMP receptors ALK2 and ALK3 were interdependently required for induction of a subset of effector genes and AICD in activated T cells, independent of their BMP ligands. Upon T cell activation, ALK2/3 were recruited to the immunological synapse and phosphorylated by PKC-θ at the conserved T203, resulting in their enhanced kinase activities. The activated ALK2/3, in the absence of BMP, phosphorylated SMAD1/5 at S57, which is reciprocally antagonistic to BMP-induced phosphorylation of SMAD1/5 at S463/465. The S57-phosphorylated SMAD1/5 associated with c-Fos to induce effector genes upon T cell activation. Disruption of Alk2 in T cells attenuated T cell-mediated immunity to Listeria, whereas blocking BMPs enhanced host defense to Listeria in WT but not Alk2-deficient mice. Our findings suggest that the BMP-independent ALK2/3-SMAD1/5 axis plays essential roles in T cell activation and AICD, which is reciprocally antagonistic with BMP-triggered inhibition of T cell-mediated immunity.</p>","PeriodicalId":15760,"journal":{"name":"Journal of Experimental Medicine","volume":"222 10","pages":""},"PeriodicalIF":10.6000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1084/jem.20250121","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Antigen recognition by TCR triggers T cell activation and activation-induced cell death (AICD). We identified that the BMP receptors ALK2 and ALK3 were interdependently required for induction of a subset of effector genes and AICD in activated T cells, independent of their BMP ligands. Upon T cell activation, ALK2/3 were recruited to the immunological synapse and phosphorylated by PKC-θ at the conserved T203, resulting in their enhanced kinase activities. The activated ALK2/3, in the absence of BMP, phosphorylated SMAD1/5 at S57, which is reciprocally antagonistic to BMP-induced phosphorylation of SMAD1/5 at S463/465. The S57-phosphorylated SMAD1/5 associated with c-Fos to induce effector genes upon T cell activation. Disruption of Alk2 in T cells attenuated T cell-mediated immunity to Listeria, whereas blocking BMPs enhanced host defense to Listeria in WT but not Alk2-deficient mice. Our findings suggest that the BMP-independent ALK2/3-SMAD1/5 axis plays essential roles in T cell activation and AICD, which is reciprocally antagonistic with BMP-triggered inhibition of T cell-mediated immunity.

免疫突触对ALK2/3的募集是T细胞激活和死亡所必需的。
TCR抗原识别触发T细胞活化和活化诱导细胞死亡(AICD)。我们发现BMP受体ALK2和ALK3在激活的T细胞中诱导一部分效应基因和AICD是相互依赖的,独立于它们的BMP配体。在T细胞活化后,ALK2/3被募集到免疫突触,并在保守的T203位点被PKC-θ磷酸化,导致其激酶活性增强。在BMP缺失的情况下,激活的ALK2/3使SMAD1/5在S57位点磷酸化,这与BMP诱导的SMAD1/5在S463/465位点的磷酸化相互拮抗。557磷酸化的SMAD1/5与c-Fos相关,诱导T细胞激活效应基因。破坏T细胞中的Alk2会减弱T细胞介导的对李斯特菌的免疫,而阻断bmp则会增强WT中宿主对李斯特菌的防御,而Alk2缺陷小鼠则不会。我们的研究结果表明,不依赖于bmp的ALK2/3-SMAD1/5轴在T细胞活化和AICD中发挥重要作用,AICD与bmp触发的T细胞介导的免疫抑制相互拮抗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
26.60
自引率
1.30%
发文量
189
审稿时长
3-8 weeks
期刊介绍: Since its establishment in 1896, the Journal of Experimental Medicine (JEM) has steadfastly pursued the publication of enduring and exceptional studies in medical biology. In an era where numerous publishing groups are introducing specialized journals, we recognize the importance of offering a distinguished platform for studies that seamlessly integrate various disciplines within the pathogenesis field. Our unique editorial system, driven by a commitment to exceptional author service, involves two collaborative groups of editors: professional editors with robust scientific backgrounds and full-time practicing scientists. Each paper undergoes evaluation by at least one editor from both groups before external review. Weekly editorial meetings facilitate comprehensive discussions on papers, incorporating external referee comments, and ensure swift decisions without unnecessary demands for extensive revisions. Encompassing human studies and diverse in vivo experimental models of human disease, our focus within medical biology spans genetics, inflammation, immunity, infectious disease, cancer, vascular biology, metabolic disorders, neuroscience, and stem cell biology. We eagerly welcome reports ranging from atomic-level analyses to clinical interventions that unveil new mechanistic insights.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信